Rockwell Medical (RMTI) EBIT Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 28.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.96% |
| Mar 31, 2026 | -1.22% |
| Dec 31, 2025 | 41.28% |
| Sep 30, 2025 | 24.69% |
| Jun 30, 2025 | 32.98% |
| Mar 31, 2025 | 41.01% |
| Dec 31, 2024 | 60.40% |
| Sep 30, 2024 | 31.57% |
| Jun 30, 2024 | 27.36% |
| Mar 31, 2024 | 43.09% |
| Dec 31, 2023 | 59.23% |
| Sep 30, 2023 | 36.20% |
| Jun 30, 2023 | 19.17% |
| Mar 31, 2023 | 43.84% |
| Dec 31, 2022 | 35.72% |
| Sep 30, 2022 | 22.42% |
| Jun 30, 2022 | 24.39% |
| Mar 31, 2022 | 9.06% |
| Dec 31, 2021 | 3.92% |
| Sep 30, 2021 | -11.73% |